scholarly journals QUALITY OF LIFE IN PATIENTS WITH CHRONIC VENOUS DISEASES AND METHODS OF ITS IMPROVEMENT (review)

2018 ◽  
Vol 5 (2) ◽  
pp. 64-68
Author(s):  
N. Pytetska
Keyword(s):  
Quality Of Life ◽  
Drug Therapy ◽  
Work Capacity ◽  
Modern Medicine ◽  
Comprehensive Analysis ◽  
New Methods ◽  
Treatment And Prevention ◽  
Venous Diseases ◽  
History Of

QUALITY OF LIFE IN PATIENTS WITH CHRONIC VENOUS DISEASES AND METHODS OF ITS IMPROVEMENT (review)N.I. Pytetska Assessment of the quality of life is one of the leading directions in modern medicine and continues to develop intensively, remaining an integral part of comprehensive analysis of new methods of diagnosis, treatment and prevention. This article provides information about the history of the concept "quality of life" and the ambiguity of terminology. Particular attention is paid to the necessity of studying this indicator in patients with chronic veins diseases, the relevance of this direction in the early stages of the disease, as well as medicines able to solve the main tasks of drug therapy, to restore work capacity and, as a result improve the patient's life quality.Key words: quality of life, chronic venous diseases, diosmin. ЯКІСТЬ ЖИТТЯ ХВОРИХ НА ХРОНІЧНІ ЗАХВОРЮВАННЯ ВЕН ТА МЕТОДИ ЇЇ ПОКРАЩЕННЯ (огляд)Питецька Н.І.Вивчення якості життя є одним із провідних напрямків сучасної медицини й продовжує інтенсивно розвиватись, залишаючись невід'ємною частиною всебічного аналізу нових методів діагностики, лікування і профілактики. У даній статті представлено інформацію про історію виникнення поняття «якість життя», неоднозначність термінології. Особливуувагу приділено необхідності оцінки даного показника у хворих на хронічні захворювання вен, актуальності цього напрямку на ранніх стадіях захворювання, а також  лікарським засобам, які здатні вирішувати основні завдання медикаментозної терапії, відновлювати працездатність і підвищувати якість життя пацієнта.Ключові слова: якість життя, хронічні захворювання вен, діосмін. КАЧЕСТВО ЖИЗНИ БОЛЬНЫХ С ХРОНИЧЕСКИМИ ЗАБОЛЕВАНИЯМИ ВЕН И МЕТОДЫ ЕГО УЛУЧШЕНИЯ (обзор)Питецкая Н.И.Изучение качества жизни является одним из ведущих направлений современной медицины и продолжает интенсивно развиваться, оставаясь неотъемлемой частью всестороннего анализа новых методов диагностики, лечения и профилактики. В данной статье представлена информация об истории возникновения понятия «качество жизни», неоднозначности терминологии. Особое внимание уделено необходимости оценки данного показателя у больных хроническими заболеванияи вен, актуальности этого направления на ранних стадиях заболевания, а также  лекарственным препаратам, которые способны решать основные задачи медикаментозной терапии, восстанавливать трудоспособность и повышать качество жизни пациента.Ключевые слова: качество жизни, хронические заболевания вен, диосмин. 

Over Warming Syndrome in Adults

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
X. Han-You
Keyword(s):  
Quality Of Life ◽  
Clinical Medicine ◽  
Clinical Symptoms ◽  
New Methods ◽  
Treatment And Prevention ◽  
Normal People ◽  
Health Level ◽  
And Behavior ◽  
Harmful Effects

Clinical significance:This article implicates that doctors must know the Over Warming Syndrome in Adults’ harmful effects, its clinical managements, imperative importance to prevent other critical diseases attacks. So that the doctors can do patient and normal people education, counsel about the new syndrome, enhance people's health level and quality of life.Objectives:Name a new kind of syndrome, in order to provide new methods of thinking and behavior for doctors to well diagnose, prevent, and treat the syndrome and other diseases and for doctors to do patient education and counseling.Method:Summarize author of this paper the self-experiences about this syndrome's clinical medicine.Results:The etiology, clinical symptoms, mechanism, diagnosis, treatment and prevention of this new syndrome are easy to understand by the doctors. Which like the symptoms of the dehydration caused by over warming.Conclusions:It is very important to name and understand this new syndrome for enhancing the human-being's health level and quality of life, preventing the human-being from development of other critical diseases. which is much too worth to be spread.

scholarly journals Effectiveness, safety and assessing the results of drug therapy in patients with epilepsy

2021 ◽  
Vol 13 (3) ◽  
pp. 306-310
Author(s):  
Article Editorial
Keyword(s):  
Quality Of Life ◽  
Drug Therapy ◽  
Antiepileptic Drugs ◽  
Psychiatric Comorbidity ◽  
Foreign Experience ◽  
History Of ◽  
Patients With Epilepsy

On June 26, 2021, a meeting of the experts of the Russian League Against Epilepsy (RLAE) was held, dedicated to the effectiveness, safety and assessing the results of drug therapy in patients with epilepsy. Having considered the history of the issue and guided by domestic and foreign experience, the participants discussed the problems associated with the use of various antiepileptic drugs for different forms of epilepsy in patients of different sex and age. Special attention was paid to psychiatric comorbidity in patients with epilepsy, increasing their compliance with treatment and quality of life. The article presents the Resolution of RLAE experts meeting adopted as a result of the discussion.

CURRENT ASPECTS OF DRUG THERAPY OF CHRONIC HEART FAILURE SYNDROME

2020 ◽  
Vol 4 (2) ◽  
pp. 1085-1096
Author(s):  
T.V. Statkevich ◽  
◽  
N.P. Mitkovskaya ◽  
◽  
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Drug Therapy ◽  
Chronic Heart Failure ◽  
Clinical Symptoms ◽  
Nyha Class ◽  
Treatment And Prevention ◽  
One Year ◽  
The One

Chronic heart failure (CHF) is an important problem for the country, which has both medical and socio-economic aspects. The presence of the syndrome not only significantly increases the risks of an unfavorable course of diseases underlying its etiological basis, but in itself, through the development of decompensation, causes a high frequency of deaths. Despite all the advances in pharmacotherapy, the prognosis of heart failure remains poor. More than 40% of patients die within 4 years after the diagnosis of heart failure, and the one-year mortality rate for patients with severe CHF (NYHA class IV) exceeds 50%. The foregoing determines the need and importance of using all possible drug and non-drug therapy technologies aimed at reducing mortality, increasing the duration and quality of life of patients with CHF, as well as reducing the number and likelihood of decompensation and related hospitalizations, and makes this direction one of the priorities in medicine. The article describes current approaches to the treatment of patients with CHF syndrome from the perspective of evidence-based medicine and taking into account the recommendations of leading international organizations for the treatment and prevention of cardiovascular diseases. The drugs used were analyzed in terms of their influence on clinical symptoms, quality of life of patients, the risk of hospitalization due to decompensation of CHF, and mortality rates. The emphasis is made on the possibilities, mechanism of action and further prospects for the use of a new class of drugs in the treatment of CHF, acting at the level of the renin-angiotensin-aldosterone system and the system of neutral endopeptidases - inhibitors of angiotensin-neprilisin receptors.

Possibilities and prospects of conservative therapy for endometriosis, as a chronical progressing disease (review of literature)

GYNECOLOGY ◽  
2020 ◽  
Vol 22 (1) ◽  
pp. 14-18 ◽  
Author(s):  
Tatyana Yu. Pestrikova ◽  
Elena A. Yurasova ◽  
Igor V. Yurasov
Keyword(s):  
Quality Of Life ◽  
Abnormal Uterine Bleeding ◽  
Modern Medicine ◽  
Reproductive Age ◽  
Aim Analysis ◽  
Scientific Publications ◽  
Terra Incognita ◽  
Positive Effect

Relevance. Endometriosis is a common gynecological disease that affects up to 10% of women of reproductive age worldwide and is the main cause of pain and infertility. Endometriosis is a disease, although it has been known for a long time, nevertheless, in many ways it represents terra incognita for modern medicine. Aim. Analysis of literature on the feasibility of long-term and the use of the drug dienogest 2 mg (Vizanne), which has a positive effect on the quality of life of patients with endometriosis. Materials and methods. To write this review, a search was made for domestic and foreign publications in Russian and international search engines (PubMed, eLibrary, etc.) over the past 13 years. The review included articles from peer-reviewed literature. Results. The review presents data on the difficulties of verifying the diagnosis of endometriosis due to a combination of this pathology with pain, infertility, abnormal uterine bleeding. The pathogenesis of the origin of endometriosis-associated pain is presented. The efficacy of the use of the drug dienogest (Vizanne), which has a powerful antiproliferative effect that reduces the main symptoms of endometriosis (pain, bleeding), is substantiated. The expediency of long-term and safe use of the drug dienogest (Vizanne), which has a positive effect on the quality of life of patients with endometriosis, has been proved. Conclusions. Numerous scientific publications confirm the feasibility of prolonged use of the drug dienogest (Vizanne), to achieve remission during endometriosis.

Patients With a History of Oronasal Fistula Repair Exhibit Lower Oral Health Measured With Patient-Centric Outcomes Measures

2020 ◽  
pp. 105566562098133
Author(s):  
Alyssa Fritz ◽  
Diana S. Jodeh ◽  
Fatima Qamar ◽  
James J. Cray ◽  
S. Alex Rottgers
Keyword(s):  
Quality Of Life ◽  
Oral Health ◽  
Cleft Palate ◽  
Fistula Repair ◽  
Old Patients ◽  
Oronasal Fistula ◽  
Patient Reported ◽  
History Of ◽  
The Impact

Introduction: Oronasal fistulae following palatoplasty may affect patients’ quality of life by impacting their ability to eat, speak, and maintain oral hygiene. We aimed to quantify the impact of previous oronasal fistula repair on patients’ quality of life using patient-reported outcome psychometric tools. Methods: A cross-sectional study of 8- to 9-year-old patients with cleft palate and/or lip was completed. Patients who had a cleft team clinic between September 2018 and August 2019 were recruited. Participants were divided into 2 groups (no fistula, prior fistula repair). Differences in the individual CLEFT-Q and Child Oral Health Impact Profile-Short Form 19 (COHIP-SF 19) Oral Health scores between the 2 groups were evaluated using a multivariate analysis controlling for Veau classification and syndromic diagnosis. Results: Sixty patients with a history of cleft palate were included. Forty-two (70%) patients had an associated cleft lip. Thirty-two (53.3%) patients had no history of fistula and 28 (46.7%) patients had undergone a fistula repair. CLEFT-Q Dental, Jaw, and Speech Function were all higher in patients without a history of a fistula repair; however, none of these differences were statistically significant. The COHIP-SF 19 Oral Health score demonstrated a significantly lower score in the fistula group, indicating poorer oral health ( P = .05). Conclusions: One would expect that successful repair of a fistula would result in improved function and patient satisfaction, but the consistent trend toward lower CLEFT-Q scores and significantly increased COHIP-SF 19 Oral Health scores in our study group suggests that residual effects linger and that the morbidity of a fistula may not be completely treated with a secondary correction.

scholarly journals Predictors of health-related quality of life in musculoskeletal disease patients: a longitudinal analysis

2021 ◽  
Vol 13 ◽  
pp. 1759720X2110340
Author(s):  
Alfredo Madrid-García ◽  
Leticia León-Mateos ◽  
Esperanza Pato ◽  
Juan A Jover ◽  
Benjamín Fernández-Gutiérrez ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Musculoskeletal Diseases ◽  
Work Capacity ◽  
Health Related Quality ◽  
Clinical Predictors ◽  
Related Quality ◽  
Health Related ◽  
Classification Index ◽  
San Carlos

Introduction: Rheumatic and musculoskeletal diseases (RMDs) have a significant impact on patients’ health-related quality of life (HRQoL) exacerbating disability, reducing independence and work capacity, among others. Predictors’ identification affecting HRQoL could help to place efforts that minimize the deleterious impact of these conditions on patients’ wellbeing. This study evaluates the influence of demographic and clinical predictors on the HRQoL of a cohort of RMD patients, measured using the Rosser classification index (RCI). Methods: We included patients attending the Hospital Clínico San Carlos (HCSC) rheumatology outpatient clinic from 1 April 2007 to 30 November 2017. The primary outcome was the HRQoL assessed in each of the patient’s visits using the RCI. Demographic and clinical variables extracted from a departmental electronic health record (EHR) were used as predictors: RMD diagnoses, treatments, comorbidities, and averaged HRQoL values from previous periods (for this last variable, values were imputed if no information was available). Association between predictors and HRQoL was analyzed using penalized generalized estimating equations (PGEEs). To account for imputation bias, the PGEE model was repeated excluding averaged HRQoL predictors, and common predictors were considered. Discussion: A total of 18,187 outpatients with 95,960 visits were included. From 410 initial predictors, 19 were independently associated with patients’ HRQoL in both PGEE models. Chronic kidney disease (CKD), an episode of prescription of third level analgesics, monoarthritis, and fibromyalgia diagnoses were associated with worse HRQoL. Conversely, the prescription in the previous visit of acid-lowering medication, colchicine, and third level analgesics was associated with better HRQoL. Conclusion: We have identified several diagnoses, treatments, and comorbidities independently associated with HRQoL in a cohort of outpatients attending a rheumatology clinic.

scholarly journals CRYOABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY AS INITIAL TREATMENT FOR ATRIAL FIBRILLATION: IMPACT ON QUALITY OF LIFE

2021 ◽  
Vol 77 (18) ◽  
pp. 225
Author(s):  
Oussama M. Wazni ◽  
Gopi Dandamudi ◽  
Nitesh Sood ◽  
Robert Hoyt ◽  
Jaret Tyler ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Atrial Fibrillation ◽  
Drug Therapy ◽  
Antiarrhythmic Drug ◽  
Initial Treatment ◽  
Antiarrhythmic Drug Therapy

Impact of a History of Hypertension on Symptoms and Quality of Life Prior to and at Five Years after Coronary Artery Bypass Grafting

2000 ◽  
Vol 9 (1) ◽  
pp. 52-63 ◽  
Author(s):  
Johan Herlitz ◽  
Kenneth Caidahl ◽  
Ingela Wiklund ◽  
Helén Sjöland ◽  
Björn Karlson ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Coronary Artery ◽  
Coronary Artery Bypass Grafting ◽  
Coronary Artery Bypass ◽  
Artery Bypass ◽  
Bypass Grafting ◽  
Artery Bypass Grafting ◽  
History Of
Sign in / Sign up

Export Citation Format

Share Document